Lubos Holubec
Pilsen, PL, Czech Republic
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Prognostic Value of EGFR Exon-20 Insertions in Czech Patients With Advanced Non-small Cell Lung Cancer.
Journal: Anticancer research
Published: September 20, 2021
Identification of tumors with NRG1 rearrangement, including a novel putative pathogenic UNC5D-NRG1 gene fusion in prostate cancer by data-drilling a de-identified tumor database.
Journal: Genes, chromosomes & cancer
Published: August 07, 2020
Evaluation of Tumor Markers and Their Impact on Prognosis in Gallbladder, Bile Duct and Cholangiocellular Carcinomas - A Pilot Study.
Journal: Anticancer research
Published: February 07, 2017
The Effectiveness of Febrile Neutropenia Prophylaxis with Lipegfilgrastim in Routine Clinical Practice.
Journal: In vivo (Athens, Greece)
Published: February 06, 2017
Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme.
Journal: Anticancer research
Published: November 15, 2016
Pre-transplant Quantitative Determination of NPM1 Mutation Significantly Predicts Outcome of AIlogeneic Hematopoietic Stem Cell Transplantation in Patients with Normal Karyotype AML in Complete Remission.
Journal: Anticancer research
Published: August 22, 2016
The Role of Cetuximab in the Induction of Anticancer Immune Response in Colorectal Cancer Treatment.
The Role of Cetuximab in the Induction of Anticancer Immune Response in Colorectal Cancer Treatment.
Journal: Anticancer research
Published: June 22, 2016
Patient-reported outcomes with lanreotide Autogel/Depot for carcinoid syndrome: An international observational study.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: September 30, 2015
Tissue Biomarkers in Predicting Response to Sunitinib Treatment of Metastatic Renal Cell Carcinoma.
Journal: Anticancer research
Published: September 27, 2015
G12V and G12A KRAS mutations are associated with poor outcome in patients with metastatic colorectal cancer treated with bevacizumab.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: July 29, 2015
The importance of early tumor shrinkage and deepness of response in assessing the efficacy of systemic anticancer treatment with metastatic colorectal cancer
Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
Published: April 18, 2015
Last Updated: 09/26/2026